CH EPL (R5)
1.0.0 - trial-use Switzerland flag

CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 IDMP Standard ISO 11615
... 3 Dataexport FOPH Spezialitätenliste
... 4 Abrilada
... 5 Cuprior
... 6 Entocort
... 7 Estalis
... 8 Keytruda
... 9 Paxlovid
... 10 Triogen
... 11 Profiles
... 12 Extensions
... 13 Terminology
... 14 Changelog
... 15 Artifacts Summary
.... 15.1 CH EPL Organization
.... 15.2 CH IDMP AdministrableProductDefinition
.... 15.3 CH IDMP ClinicalUseDefinition Indication
.... 15.4 CH IDMP DocumentReference
.... 15.5 CH IDMP ManufacturedItemDefinition
.... 15.6 IDMP Bundle
.... 15.7 IDMP Ingredient
.... 15.8 IDMP MedicinalProductDefinition
.... 15.9 IDMP PackagedProductDefinition
.... 15.10 IDMP RegulatedAuthorization
.... 15.11 FOPH Dossier Number
.... 15.12 GLN Identifier
.... 15.13 LOC Identifier
.... 15.14 CH - EPL Product Price
.... 15.15 CH - EPL Regulated Authorization Limitation
.... 15.16 CH - EPL Reimbursement SL
.... 15.17 CH - SMC Authorized Dose Form
.... 15.18 CH - Authorisation Type
.... 15.19 CH - Medicinal Product Name Type
.... 15.20 CH - Other Characteristics Type
.... 15.21 CH EPL - Gamme
.... 15.22 CH EPL - Index Therapeuticus
.... 15.23 CH EPL - Limitation Status
.... 15.24 CH EPL - Listing Status
.... 15.25 CH EPL - Other Characteristics Packaged Item
.... 15.26 CH EPL - Price Type
.... 15.27 CH EPL - Product Type
.... 15.28 CH EPL - Reimbursement Status
.... 15.29 CH EPL - Type of Price Change
.... 15.30 CH SMC - Additional Monitoring Indicator
.... 15.31 CH SMC - Attached Document Type
.... 15.32 CH SMC - Authorisation Category
.... 15.33 CH SMC - Authorisation Status
.... 15.34 CH SMC - Authorised Pharmaceutical Dose Form
.... 15.35 CH SMC - Ingredient Role
.... 15.36 CH SMC - Legal Status of Supply
.... 15.37 CH SMC - Marketing Status
.... 15.38 CH SMC - Pediatric Use Indicator
.... 15.39 CH SMC - Special Precautions for Storage
.... 15.40 CH SMC - Substance
.... 15.41 CH SMC - TherapeuticProductcode
.... 15.42 EDQM - Combination Packaging
.... 15.43 EDQM - Combined Pharmaceutical Dose Form
.... 15.44 EDQM - Combined Term
.... 15.45 EDQM - Packaging
.... 15.46 EDQM - Pharmaceutical Dose Form
.... 15.47 EDQM - Route Of Administration
.... 15.48 EDQM - Unit of Presentation
.... 15.49 EMA - Domain
.... 15.50 EMA - Intended Effect
.... 15.51 EMA - Shelf Life Type
.... 15.52 CH - Authorisation Type
.... 15.53 CH - Medicinal Product Name Type
.... 15.54 CH - Other Characteristics Type
.... 15.55 CH EPL - Gamme
.... 15.56 CH EPL - Index Therapeuticus
.... 15.57 CH EPL - Limitation Status
.... 15.58 CH EPL - Listing Status
.... 15.59 CH EPL - Other Characteristics Packaged Item
.... 15.60 CH EPL - Price Type
.... 15.61 CH EPL - Product Type
.... 15.62 CH EPL - Reimbursement Status
.... 15.63 CH EPL - Type of Price Change
.... 15.64 CH SMC - Additional Monitoring Indicator
.... 15.65 CH SMC - Attached Document Type
.... 15.66 CH SMC - Authorisation Category
.... 15.67 CH SMC - Authorisation Status
.... 15.68 CH SMC - Ingredient Role
.... 15.69 CH SMC - Legal Status of Supply
.... 15.70 CH SMC - Marketing Status
.... 15.71 CH SMC - Pediatric Use Indicator
.... 15.72 CH SMC - Special Precautions for Storage
.... 15.73 CH SMC - Substance
.... 15.74 CH SMC - TherapeuticProductcode
.... 15.75 EDQM - Standard Terms
.... 15.76 EMA - Domain
.... 15.77 EMA - Intended Effect
.... 15.78 EMA - Shelf Life Type
.... 15.79 Application / Assessment Tracking Number
.... 15.80 Clinical Product Identifier
.... 15.81 FOPH Dossier Number
.... 15.82 GLN Identifier
.... 15.83 Global Trade Item Number
.... 15.84 LOC Identifier
.... 15.85 Marketing Authorisation Number
.... 15.86 Medical Product Identifier
.... 15.87 Pharmaceutical Product Identifier
.... 15.88 5204201
.... 15.89 52042011
.... 15.90 5470402
.... 15.91 54704089
.... 15.92 66231001
.... 15.93 6623101
.... 15.94 67431001
.... 15.95 6743101
.... 15.96 67719001
.... 15.97 6771901
.... 15.98 67831001
.... 15.99 67831001
.... 15.100 6783101
.... 15.101 68793001
.... 15.102 6879301
.... 15.103 ABRILADA Inj Lös 40 mg/0.8ml Fertpen 0.8 ml (Bundle)
.... 15.104 Abrilada, Injektionslösung
.... 15.105 Abrilada, Injektionslösung Fachinformation
.... 15.106 Abrilada, Injektionslösung Fachinformation
.... 15.107 CH-52042011
.... 15.108 CH-54704089
.... 15.109 CH-66231001
.... 15.110 CH-67431001
.... 15.111 CH-67831001
.... 15.112 CH-67831002
.... 15.113 CH-68291001
.... 15.114 CH-68793001
.... 15.115 CUPRIOR Filmtabl 150 mg (Bundle)
.... 15.116 CUPRIOR Filmtabl 150 mg 72 Stk
.... 15.117 Cuprior, Filmtabletten Fachinformation
.... 15.118 Cuprior, Filmtabletten Patienteninformation
.... 15.119 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk
.... 15.120 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk (Bundle)
.... 15.121 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk Fachinformation
.... 15.122 ENTOCORT Enema Klistier Lösung + Tabletten 7 Stk Patienteninformation
.... 15.123 ESTALIS Matrixpfl 50/250 24 Stk
.... 15.124 ESTALIS Matrixpfl 50/250 24 Stk (Bundle)
.... 15.125 ESTALIS Matrixpfl 50/250 24 Stk Fachinformation
.... 15.126 ESTALIS Matrixpfl 50/250 24 Stk Patienteninformation
.... 15.127 Indication 10002556
.... 15.128 Indication 10003268
.... 15.129 Indication 10009900
.... 15.130 Indication 10019927
.... 15.131 Indication 10020041
.... 15.132 Indication 10021782
.... 15.133 Indication 10027400
.... 15.134 Indication 10028881
.... 15.135 Indication 10030247
.... 15.136 Indication 10031285
.... 15.137 Indication 10037153
.... 15.138 Indication 10037160
.... 15.139 Indication 10043971
.... 15.140 Indication 10045365
.... 15.141 Indication 10046851
.... 15.142 Indication 10061091
.... 15.143 Indication 10075566
.... 15.144 Indication 10084529
.... 15.145 Indication 10089182
.... 15.146 KEYTRUDA Inf Konz 100 mg / 4 ml
.... 15.147 KEYTRUDA Inf Konz 100 mg / 4 ml (Bundle)
.... 15.148 Keytruda, Konzentrat zur Herstellung einer Infusionslösung Fachinformation
.... 15.149 Limitation 156370009
.... 15.150 Limitation 254837009
.... 15.151 Limitation 34000006
.... 15.152 Limitation 59393003
.... 15.153 Limitation 64766004
.... 15.154 Limitation 69896004
.... 15.155 Limitation 79886009
.... 15.156 Limitation 840539006
.... 15.157 Limitation 9014002
.... 15.158 Limitation 9631008
.... 15.159 MI Abrilada-40mg-Pre-Filled-Pen
.... 15.160 MI Budesonidum-2.3mg-Tablet
.... 15.161 MI Estradiol-hemihydrate-Norethisteroni-acetas-Transdermal-patch
.... 15.162 MI Nirmatrelvir-150mg-Tablet
.... 15.163 MI Pembrolizumab-100mg-Vial
.... 15.164 MI Ritonavirum-100mg-Tablet
.... 15.165 MI Solvent
.... 15.166 MI Trientinum-150mg-Tablet
.... 15.167 MI Trientinum-250mg-Capsule
.... 15.168 PAXLOVID Filmtabl 4x150mg/2x100mg
.... 15.169 PAXLOVID Filmtabl 4x150mg/2x100mg (Bundle)
.... 15.170 Paxlovid, Filmtabletten Patienteninformation
.... 15.171 PhP Abrilada-40mg-Pre-Filled-Pen
.... 15.172 PhP Budesonidum-Suspension
.... 15.173 PhP Estradiol-hemihydrate and Norethisteroni-acetas Transdermal-patch
.... 15.174 PhP Pembrolizumab-100mg-Vial
.... 15.175 PhP Trientinum-150mg-Tablet
.... 15.176 PhP Trientinum-150mg-Tablet
.... 15.177 PhP-Nirmatrelvir-150mg-Filmcoatedtablet
.... 15.178 PhP-Ritonavirum-100mg-Filmcoatedtablet
.... 15.179 Professional Information Paxlovid, Filmtabletten Fachinformation
.... 15.180 Reimbursement SL 17418
.... 15.181 Reimbursement SL 17973
.... 15.182 Reimbursement SL 20416
.... 15.183 Reimbursement SL 21070
.... 15.184 Reimbursement SL 21203 1 Pre-Filled Pen
.... 15.185 Reimbursement SL 21203 2 Pre-Filled Pen
.... 15.186 Reimbursement SL 21208
.... 15.187 Reimbursement SL 21529
.... 15.188 TRIOGEN Kaps 250 mg Ds 100 Stk
.... 15.189 TRIOGEN Kaps 250 mg Ds 100 Stk (Bundle)
.... 15.190 Triogen, Kapseln Fachinformation
.... 15.191 Triogen, Kapseln Patienteninformation